公开(公告)号：US20240342169A1

公开(公告)日：2024-10-17

申请号：US18682227

申请日：2022-08-04

Applicant: BETTA PHARMACEUTICALS CO., LTD

Inventor： Lijia LIU ,  Jing GUO ,  Yu WANG ,  Xiangdong ZHAO ,  Jie CHEN ,  Yang WANG ,  Xiaobin YUAN ,  Dong JI ,  Licheng KONG ,  Lieming DING

IPC: A61K31/501 ,  A61P35/00

CPC classification number: A61K31/501 ,  A61P35/00

Abstract: Embodiments of the present application provide Ensartinib or a salt thereof and a use of a composition containing Ensartinib or the salt thereof in treatment of a disease carrying MET 14 exon skipping mutation.